Page 63 - e-CPG-SLE-8_5_24
P. 63
Management of Systemic Lupus Erythematosus
REFERENCES
1. Urowitz MB, Gladman DD, Tom BD, et al. Changing patterns in mortality and
disease outcomes for patients with systemic lupus erythematosus. J Rheumatol.
2008;35(11):2152-2158.
2. Jakes RW, Bae SC, Louthrenoo W, et al. Systematic review of the epidemiology of
systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence,
clinical features, and mortality. Arthritis Care Res (Hoboken). 2012;64(2):159-
168.
3. Teh CL, Ling GR. Causes and predictors of mortality in hospitalized lupus patient
in Sarawak General Hospital, Malaysia. Lupus. 2013;22(1):106-111.
4. van Vollenhoven RF, Mosca M, Bertsias G, et al. Treat-to-target in systemic
lupus erythematosus: recommendations from an international task force. Ann
Rheum Dis. 2014;73(6):958-967.
5. Mok CC, Hamijoyo L, Kasitanon N, et al. The Asia-Pacific League of Associations
for Rheumatology consensus statements on the management of systemic lupus
erythematosus. Lancet Rheumatol. 2021;3(7):e517-e531.
6. Malaysian SLE Association. What is SLE? Malaysian SLE Association; 2023.
[Available at: https://lupusmalaysia.org/what-is-sle/]
7. Kuo CF, Grainge MJ, Valdes AM, et al. Familial Aggregation of Systemic
Lupus Erythematosus and Coaggregation of Autoimmune Diseases in Affected
Families. JAMA Intern Med. 2015;175(9):1518-1526.
8. Selvaraja M, Too CL, Tan LK, et al. Human leucocyte antigens profiling in
Malay female patients with systemic lupus erythematosus: are we the same or
different? Lupus Sci Med. 2022;9(1):e000554.
9. Selvaraja M, Chin VK, Abdullah M, et al. HLA-DRB1(*)04 as a Risk Allele to
Systemic Lupus Erythematosus and Lupus Nephritis in the Malay Population of
Malaysia. Front Med (Lausanne). 2021;7:598665.
10. Charoenngam N, Ponvilawan B, Wongtrakul W, et al. Patients with asthma have
a higher risk of systemic lupus erythematosus: a systematic review and meta-
analysis. Clin Rheumatol. 2021;40(2):529-536.
11. Hsiao YP, Tsai JD, Muo CH, et al. Atopic diseases and systemic lupus
erythematosus: an epidemiological study of the risks and correlations. Int J
Environ Res Public Health. 2014;11(8):8112-8122.
12. Parisis D, Bernier C, Chasset F, et al. Impact of tobacco smoking upon disease
risk, activity and therapeutic response in systemic lupus erythematosus: A
systematic review and meta-analysis. Autoimmun Rev. 2019;18(11):102393.
13. Morotti A, Sollaku I, Catalani S, et al. Systematic review and meta-analysis of
epidemiological studies on the association of occupational exposure to free
crystalline silica and systemic lupus erythematosus. Rheumatology (Oxford).
2020;60(1):81-91.
14. Finckh A, Cooper GS, Chibnik LB, et al. Occupational silica and solvent
exposures and risk of systemic lupus erythematosus in urban women. Arthritis
Rheum. 2006;54(11):3648-3654.
15. Rojas-Villarraga A, Torres-Gonzalez JV, Ruiz-Sternberg AM. Safety of hormonal
replacement therapy and oral contraceptives in systemic lupus erythematosus: a
systematic review and meta-analysis. PLoS One. 2014;9(8):e104303.
16. Nightingale AL, Davidson JE, Molta CT, et al. Presentation of SLE in UK
primary care using the Clinical Practice Research Datalink. Lupus Sci Med.
2017;4(1):e000172.
17. Voulgarelis M, Kokori SI, Ioannidis JP, et al. Anaemia in systemic lupus
erythematosus: aetiological profile and the role of erythropoietin. Ann Rheum
Dis. 2000;59(3):217-222.
46